colorectal cancer. Malignant neoplasm of colon
Conditions
Interventions
Intervention 1: Patients in main group received standardized capsules containing in Apium graveolens L.fruit for 12 courses daily with 8h spans. They were informed of consumption instructions and tim
Treatment - Drugs
Placebo
Patients in main group received standardized capsules containing in Apium graveolens L.fruit for 12 courses daily with 8h spans. They were informed of consumption instructions and time. Patients were
Patients in main group received standardized capsules containing in cellulose for 12 courses daily with 8h spans. They were informed of consumption instructions and time.
Sponsors
Yazd University of Medical Science
Eligibility
Sex/Gender
All
Age
20 Years to 80 Years
Inclusion criteria
Inclusion criteria: Enclusion criteria: Patient must be suffering from colorectal cancer; Patient must be between 20 to 80 years old; The patient must have received folfox diet containing folinic acid; 5-fluro uracil and oxaliplatin; Full satisfaction of the patient Exclusion criteria: Patients who take acupuncture during their treatment; Patients who receive massage therapy during their treatment; Patients who receive physiotherapy during their treatment; Patients who take indigenous medicine; Patients with previously-diagnosed neuropathy; Patients with lupus or rheumatoid arteritis; Patients with other forms of cancer
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The pain. Timepoint: Beforetreatment, 5 to 6 months after treatment. Method of measurement: Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAlimohamad Ranjbar Jamal abadi
Yazd University of Medical Sciences
Outcome results
None listed